Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Renal Colic

In brief

This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.

Key facts

Study ID

NCT06345716

Run by

University of Monastir

People needed

1500

Starts

2024-04-10

Expected to finish

2025-11-30

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• -Age > 18 years old.
• Consent to participate in the study.
• Pain in the flank/lumbar fossa of sudden onset with urine strips and/or imaging corresponding to the diagnosis of renal colic.
• Pain score at discharge < 30 (visual analog scale - VAS or verbal numerical scale - VAS from 0 to 100).

You may not qualify if…

• -Inability to appreciate pain according to the VAS.
• Pregnant or breastfeeding woman.
• Renal insufficiency with creatinine clearance < 60 ml/min.

Where it is running

• Semir Nouira — Monastir, Tunisia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.